SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-15-308060
Filing Date
2015-08-31
Accepted
2015-08-31 15:01:11
Documents
1
Group Members
GARY LITTLEGARY MORGENTHALERJOHN LUTSIMORGENTHALER MANAGEMENT PARTNERS VIII, LLCRALPH CHRISTOFFERSENROBERT BELLASROBERT PAVEY

Document Format Files

Seq Description Document Type Size
1 SC 13D d73741dsc13d.htm SC 13D 152590
  Complete submission text file 0001193125-15-308060.txt   154274
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82442 | Film No.: 151084644
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 PUBLIC SQUARE STE 2700 CLEVELAND OH 44113
Business Address 50 PUBLIC SQUARE STE 2700 CLEVELAND OH 44113
Morgenthaler Partners VIII LP (Filed by) CIK: 0001352701 (see all company filings)

IRS No.: 000000000
Type: SC 13D